Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

Recent & Breaking News (TSX:MBX)

Microbix Presenting at Capital Conference in B.C.

GlobeNewswire February 17, 2022

Microbix Advances Commissioning of Sites Two and Three

GlobeNewswire February 15, 2022

Microbix Reports Record Results for Q1 Fiscal 2022

GlobeNewswire February 10, 2022

Microbix Launches Omicron Variant Test Control

GlobeNewswire February 1, 2022

Microbix (TSX:MBX) receives $4.7M order

Trevor Abes  December 24, 2021

Microbix Receives $4.7 Million Order for Viral Transport Medium

GlobeNewswire December 24, 2021

Microbix (TSX:MBX) reports record results for 2021

Julia Kennedy  December 23, 2021

Microbix Reports Record Results for Fiscal 2021

GlobeNewswire December 23, 2021

Microbix Launches Multiplex Respiratory PCR-Test Control

GlobeNewswire December 20, 2021

Microbix Expands Pandemic Test Controls (QAPs(TM)) Portfolio

GlobeNewswire November 17, 2021

Microbix Receives $2.7 Million from Exercise of Warrants

GlobeNewswire October 27, 2021

Microbix Makes Early Repayment of 9% Interest Debenture

GlobeNewswire October 4, 2021

Microbix Presenting Product Results at AACC

GlobeNewswire September 27, 2021

Microbix Presenting at Muskoka Capital Conference

GlobeNewswire September 23, 2021

Microbix Reports Record Results for Q3 Fiscal 2021

GlobeNewswire August 12, 2021

Microbix Upgrades U.S. OTC Market & Investor Relations

GlobeNewswire August 3, 2021

Microbix Presenting Product Results to Industry

GlobeNewswire July 8, 2021

Microbix Announces Quality Products Distribution Agreement

GlobeNewswire July 7, 2021

Microbix (TSX:MBX) secures third manufacturing site in Ontario

Trevor Abes  June 3, 2021

Microbix Secures Third Ontario Manufacturing Site

GlobeNewswire June 3, 2021